Medicine that help in leprosy nerve problem
Phase 3
- Conditions
- Health Condition 1: A30- Leprosy [Hansens disease]
- Registration Number
- CTRI/2023/10/059232
- Lead Sponsor
- All India institute of Medical Sciences Raipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Those willing to participate.
2. Age group between 18-60 yrs.
3. Newly diagnosed leprosy patients with abnormal Nerve conduction study
Exclusion Criteria
1. Subject with significant spinal, renal, hepatic
impairment, diabetes and fixed deformities.
2. Subject with known hypersensitivity with
antioxidants.
3. Pregnancy and Lactating mothers.
4. Diagnosed case of neuropathy related to other
causes
5. Leprosy patients on thalidomide and/or
minocycline treatment.
6. Newly diagnosed leprosy patients receiving any
other antioxidants
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method